全文获取类型
收费全文 | 4049篇 |
免费 | 526篇 |
国内免费 | 66篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 97篇 |
妇产科学 | 218篇 |
基础医学 | 579篇 |
口腔科学 | 67篇 |
临床医学 | 549篇 |
内科学 | 1091篇 |
皮肤病学 | 62篇 |
神经病学 | 328篇 |
特种医学 | 108篇 |
外科学 | 437篇 |
综合类 | 60篇 |
预防医学 | 180篇 |
眼科学 | 64篇 |
药学 | 387篇 |
中国医学 | 36篇 |
肿瘤学 | 310篇 |
出版年
2023年 | 29篇 |
2022年 | 73篇 |
2021年 | 131篇 |
2020年 | 97篇 |
2019年 | 157篇 |
2018年 | 149篇 |
2017年 | 127篇 |
2016年 | 156篇 |
2015年 | 170篇 |
2014年 | 171篇 |
2013年 | 253篇 |
2012年 | 281篇 |
2011年 | 244篇 |
2010年 | 214篇 |
2009年 | 168篇 |
2008年 | 223篇 |
2007年 | 243篇 |
2006年 | 202篇 |
2005年 | 189篇 |
2004年 | 157篇 |
2003年 | 127篇 |
2002年 | 125篇 |
2001年 | 93篇 |
2000年 | 105篇 |
1999年 | 89篇 |
1998年 | 34篇 |
1997年 | 33篇 |
1996年 | 28篇 |
1995年 | 23篇 |
1994年 | 19篇 |
1993年 | 32篇 |
1992年 | 61篇 |
1991年 | 41篇 |
1990年 | 32篇 |
1989年 | 43篇 |
1988年 | 44篇 |
1987年 | 29篇 |
1986年 | 17篇 |
1985年 | 25篇 |
1984年 | 22篇 |
1983年 | 16篇 |
1980年 | 13篇 |
1979年 | 18篇 |
1978年 | 12篇 |
1976年 | 9篇 |
1975年 | 14篇 |
1974年 | 10篇 |
1973年 | 11篇 |
1972年 | 11篇 |
1971年 | 11篇 |
排序方式: 共有4641条查询结果,搜索用时 8 毫秒
91.
92.
93.
94.
Rie Yamamoto Hiroshi Akazawa Kaoru Ito Haruhiro Toko Masanori Sano Noritaka Yasuda Yingjie Qin Yoko Kudo Takeshi Sugaya Kenneth R Chien Issei Komuro 《Circulation journal》2007,71(12):1958-1964
BACKGROUND: Angiotensin II (AT) is implicated in the development of cardiac remodeling, which leads to heart failure, and pharmacological inhibition of the AT type 1 (AT1) receptor has improved mortality and morbidity in patients of heart failure. The aim of this study was to elucidate the role of the AT1 receptor in disease progression in muscle LIM protein (MLP)-deficient mice, which are susceptible to heart failure because of defective function of mechanosensors in cardiomyocytes. METHOD AND RESULTS: Hearts from MLP knockout (MLPKO) mice and MLP-AT1a receptor double knockout (DKO) mice were analyzed. MLPKO hearts showed marked chamber dilatation with cardiac fibrosis and reactivation of the fetal gene program. All of these changes were significantly milder in the DKO hearts. Impaired left ventricular (LV) contractility and filling were alleviated in DKO hearts. However, the impaired relaxation and downregulated expression of sarcoplasmic reticulum calcium-ATPase 2 were unchanged in DKO hearts. CONCLUSIONS: The AT1a receptor is involved in progression of LV remodeling and deterioration of cardiac function in the hearts of MLPKO mice. These results suggest that blockade of the receptor is effective in preventing progression of heart failure in dilated cardiomyopathy. 相似文献
95.
Limb salvage is now more common than amputation after radical excision to treat malignant tumors. In a skeletally immature patient who has malignant tumors in a lower extremity, rotationplasty offers a more reliable and durable option than other limb salvage procedures. It is an excellent method of resolving the problem of unequal leg lengths, and preserves best limb function with few complications. Here, we present our experience with rotationplasty for limb salvage in the treatment of malignant tumors, with good functional results seen in follow-up examination 11 years after surgery. 相似文献
96.
Rosiglitazone improves insulin sensitivity and glucose tolerance in subjects with impaired glucose tolerance 总被引:2,自引:0,他引:2
Hung YJ Hsieh CH Pei D Kuo SW Lee JT Wu LY He CT Lee CH Fan SC Sheu WH 《Clinical endocrinology》2005,62(1):85-91
OBJECTIVE: This study was designed to evaluate the effects of rosiglitazone (ROS) on insulin sensitivity, beta-cell function, and glycaemic response to glucose challenge and meal in subjects with impaired glucose tolerance (IGT). METHODS: Thirty patients with IGT (ages between 30 and 75 years and BMI (body mass index) < or = 27 kg/m2) were randomly assigned to receive either placebo (n = 15) or ROS (4 mg/day) (n = 15). All participants underwent a 75-g oral glucose tolerance test (OGTT), meal test, and frequently sampled intravenous glucose tolerance test (FSIGT) before and after the 12-week treatment. RESULTS: After 12 weeks of ROS treatment, there were significant increases in total cholesterol (TC) (4.25 +/- 0.22 vs 4.80 +/- 0.17 mmol/l, P < 0.001), high-density lipoprotein cholesterol (HDL-C) (1.25 +/- 0.07 vs 1.43 +/- 0.06 mmol/l, P < 0.05), and low-density lipoprotein cholesterol (LDL-C) (2.70 +/- 0.15 vs 3.37 +/- 0.17 mmol/l, P < 0.05) without changes in triglyceride concentration, TC/HDL-C and LDL-C/HDL-C ratio. Although the acute insulin response (AIR) to intravenous glucose and disposition index (measured as the ability of pancreatic beta-cell compensation in the presence of insulin resistance) remained unchanged, the insulin sensitivity (SI) and glucose effectiveness (SG) were remarkably elevated (0.38 +/- 0.06 vs 0.54 +/- 0.09 x 10(-5) min(-1)/pmol, P < 0.05; 0.017 +/- 0.002 vs 0.021 +/- 0.001 min(-1), P < 0.05, respectively) in the ROS group. The glucose, insulin, and c-peptide areas under curve (AUC) in response to OGTT and the glucose and insulin AUC during meal were significantly ameliorated in the ROS group. Five out of 15 (33%) and two out of 15 (13%) subjects treated with ROS and placebo, respectively, reversed to normal response during OGTT (P < 0.05). CONCLUSION: Rosiglitazone treatment significantly improved insulin resistance and reduced postchallenge glucose and insulin concentrations in patients with impaired glucose tolerance without remarkable effects on beta-cell secretory function. 相似文献
97.
98.
Mark B. Landon Madeline Murguia Rice Michael W. Varner Brian M. Casey Uma M. Reddy Ronald J. Wapner Dwight J. Rouse Joseph R. Biggio Jr. John M. Thorp Edward K. Chien George Saade Alan M. Peaceman Sean C. Blackwell J. Peter VanDorsten 《Diabetes care》2015,38(3):445-452
OBJECTIVETo evaluate whether treatment of mild gestational diabetes mellitus (GDM) confers sustained offspring health benefits, including a lower frequency of obesity.RESULTSFive hundred of 905 eligible offspring (55%) were enrolled. Maternal baseline characteristics were similar between the follow-up treated and untreated groups. The frequencies of BMI ≥95th (20.8% and 22.9%) and 85th (32.6% and 38.6%) percentiles were not significantly different in treated versus untreated offspring (P = 0.69 and P = 0.26). No associations were observed for BMI z score, log waist circumference, log triglycerides, HDL cholesterol, blood pressure, or log HOMA-estimated insulin resistance (HOMA-IR). The effect of treatment was different by sex for fasting glucose and log HOMA-IR (P for interaction = 0.002 and 0.02, respectively) but not by age-group (5–6 and 7–10 years) for any outcomes. Female offspring of treated women had significantly lower fasting glucose levels.CONCLUSIONSAlthough treatment for mild GDM has been associated with neonatal benefits, no reduction in childhood obesity or metabolic dysfunction in the offspring of treated women was found. However, only female offspring of women treated for mild GDM had lower fasting glucose. 相似文献
99.
100.